CD274 and lymphoma: In lymphoma patients, however, there may be upregulation of the PD-L1 and/or PD-L2 expression on the malignant cells that inhibits the T cell response and results in a state of reduced T cell differentiation, decreased proliferation, and suppressed effector function.